Incyte Corporation (INCY) is listed on NASDAQ in Healthcare Services Stocks. It is $124.39, -2.63%, with a $24.8B market cap. RSI is 54.2, neutral. The latest reported quarter beat estimates. Insiders were net sellers across the listed trades.
Technical Analysis
RSI (14) 54.2 Neutral
Market Cap $24.8B
Volume 1.6M
Fundamentals — 10-Q Q1 2026
Revenue $1.3B
Net Income $303.3M
EPS $1.47
Gross Margin 91.8%
Operating Margin 23.7%
Net Margin 23.8%
P/E Ratio 84.6x
Earnings
Recent Insider Trades
| Name | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| Cagnoni Pablo J | President, Global Head of R&D | Sell | 10,801 | $125.56 | $1.4M | 2026 Aug 19 |
| Cagnoni Pablo J | President, Global Head of R&D | Sell | 10,803 | $120.04 | $1.3M | 2026 Aug 12 |
| Cagnoni Pablo J | President, Global Head of R&D | Sell | 10,640 | $122.69 | $1.3M | 2026 Aug 5 |
| Mayes Patrick A | EVP & Chief Scientific Officer | Sell | 2,207 | $123.99 | $273,646 | 2026 Aug 5 |
| Mayes Patrick A | EVP & Chief Scientific Officer | Sell | 47,954 | $119.58 | $5.7M | 2026 Aug 3 |
| Cagnoni Pablo J | President, Global Head of R&D | Sell | 15,888 | $119.70 | $1.9M | 2026 Jul 31 |
| Stein Steven H | CMO & Head of Late-Stage Dev. | Sell | 1,877 | $114.73 | $215,348 | 2026 Jul 16 |
| Issa Mohamed Khairie | EVP, Head of U.S. Commercial | Sell | 1,093 | $115.01 | $125,706 | 2026 Jul 16 |
| Stein Steven H | CMO & Head of Late-Stage Dev. | Sell | 28,237 | $113.05 | $3.2M | 2026 Jul 15 |
| Tray Thomas | Principal Accounting Officer | Sell | 2,639 | $100.00 | $263,900 | 2026 Jun 4 |
| Tray Thomas | Principal Accounting Officer | Sell | 2,051 | $97.35 | $199,665 | 2026 May 26 |
| Clancy Paul J | Director | Sell | 15,000 | $94.93 | $1.4M | 2026 May 19 |
| Cagnoni Pablo J | President, Global Head of R&D | Sell | 18,667 | $96.50 | $1.8M | 2026 Apr 17 |
| Cagnoni Pablo J | President, R&D | Sell | 18,667 | $94.24 | $1.8M | 2026 Mar 17 |
| Cagnoni Pablo J | President, R&D | Sell | 18,668 | $100.91 | $1.9M | 2026 Feb 19 |
| Tray Thomas | Principal Accounting Officer | Sell | 3,374 | $99.69 | $336,350 | 2025 Dec 19 |
| Morrissey Michael James | EVP, Head of Tech. Operations | Sell | 58,331 | $97.29 | $5.7M | 2025 Dec 17 |
| Mayes Patrick A | EVP & Chief Scientific Officer | Sell | 5,808 | $95.55 | $554,965 | 2025 Dec 11 |
| Stein Steven H | EVP & Chief Medical Officer | Sell | 22,664 | $102.56 | $2.3M | 2025 Dec 2 |
| Tray Thomas | Principal Accounting Officer | Sell | 769 | $102.78 | $79,038 | 2025 Nov 24 |
Other Healthcare Services Stocks
| Ticker | Price | RSI | Mkt Cap |
|---|---|---|---|
| | $894.35 | 58.3 | $104.3B |
| | $417.60 | 60.5 | $92.6B |
| | $321.94 | 56.1 | $61.4B |
| | $180.73 | 32.4 | $11.5B |
| | $89.49 | 56.4 | $10.0B |
| | $171.73 | 58.3 | $10.4B |
| | $172.95 | 41.0 | $10.1B |
Take INCY further
- Browse Healthcare Services Stocks for the rest of the group, with what the businesses in it have in common and where they differ.
- Put INCY in a portfolio and see what it does to total return, drawdown, and how the rest of your holdings move with it. Compares against the S&P 500 over the same days, free and without an account.
- Screen for others like it by RSI, valuation, market cap, and insider activity.
- Check the earnings calendar for when Incyte Corporation next reports.
Set alerts on INCY
Get notified when Incyte Corporation hits your price targets or technical conditions are met.
Get Started Free